<![CDATA[A Phase 1 trial by WashU and Mass General Brigham shows a personalized DNA vaccine extends survival in glioblastoma patients by targeting 40 distinct tumor proteins.]]>A Phase 1 trial by WashU and Mass General Brigham shows a personalized DNA vaccine extends survival in glioblastoma patients by targeting 40 distinct tumor proteins.
https://blazetrends.com/how-a-custom-dna-vaccine-is-finally-breaking-through-glioblastoma-defenses/?fsp_sid=12975

]]>https://postcall.pub/topic/33dda250-1af1-4903-876f-8784ce0c4d07/a-phase-1-trial-by-washu-and-mass-general-brigham-shows-a-personalized-dna-vaccine-extends-survival-in-glioblastoma-patients-by-targeting-40-distinct-tumor-proteins.RSS for NodeMon, 25 May 2026 01:39:47 GMTThu, 14 May 2026 01:24:35 GMT60